Synthetic Biology: Minimal cells, maximal knowledge
Modeling all the chemical reactions that take place in a minimal cell will help us to understand the fundamental interactions that power life.
- Université de Sherbrooke, Canada
- University of California, United States
- Technical University of Denmark, Denmark
- University of California, Unites States
If we could map and understand every single molecular process in a cell, we would have a better grasp of the fundamental principles of life. We could ultimately use this knowledge to design and create artificial organisms. An obvious way to start this endeavor is to study minimal cells, natural or synthetic organisms that contain only the bare minimum of genetic information needed to survive. By building and studying these very simplified cells – so simple they have been described as the ‘hydrogen atoms of biology’ (Morowitz, 1984) – we may be able to dissect all the molecular mechanisms required to sustain cellular life.
The elucidation of the DNA double helix in 1953, and the subsequent cracking of the genetic code, made it possible to link molecular processes to DNA sequences (Figure 1). In turn, whole genome sequencing has revealed a collection of molecular roles encoded in the genomes of a great number of organisms, starting in 1995 with the first complete bacterial genomes (Fleischmann et al., 1995; Fraser et al., 1995), and then expanding thanks to next-generation sequencing methods (McGuire et al., 2008; Spencer, 2008). Yet, this has also showed that we do not know or can only guess the roles of many genes which are essential to life.
Figure 1
Synthetic biology and minimal cells: an historical perspective.
Elucidating the DNA double helix marked the beginning of the molecular biology era, and it became possible to study molecular mechanisms that underpinned observable phenotypes. DNA sequencing methods improved, leading to whole-genome sequencing at the end of the 1990s. Methods for mathematical cell modeling were developed during the 1980s and 1990s, and computer simulations of metabolic networks (also known as genome-scale models of metabolism, or GEMs) could be reconstructed. A defining moment took place in 2008 (red), with the creation of the first artificial genome that mimicked the genetic information of M. genitalium, the free-living, non-synthetic organism with the smallest genome. Thanks to developments in next-generation sequencing methods, this was paired with the rise of large-scale genome sequencing ventures, such as the human microbiome and the 1000 genomes projects. Advances in whole-genome synthesis, assembly, and transplantation helped create the first cell living with an entirely synthetic genome shortly after. Taken together, these achievements marked the coming of age for synthetic biology.
In 2008, as large-scale sequencing projects were initiated, a group of scientists at the J. Craig Venter Institute (JCVI) artificially recreated the genome of a bacterium. The team made DNA fragments in the laboratory, and then used a combination of chemistry and biology techniques to assemble the pieces ‘in the right order’, using the genetic information of the Mycoplasma genitalium bacteria as a template (Gibson et al., 2008). This marked a significant branching point in the history of biology: while the previous decades had focused on acquiring as much knowledge as possible about natural organisms, creating a genome from scratch in a laboratory demonstrated the potential to design synthetic cells (Figure 1). This shifted synthetic biology, the field in which researchers try to build biological entities, towards an engineering discipline that could work at the scale of a genome. The same team then went on to build Mycoplasma mycoides JCVI-syn1.0, the first living cell with an entirely artificial chromosome (Gibson et al., 2010). In both cases, the artificial genetic information faithfully replicated that found in the wild-type bacteria.
The next goal was to piece together an artificial genome that contains only those genes that are absolutely necessary for life and growth. In 2016, after years of design and testing, the genetic information in JCVI-syn1.0 was whittled down to produce M. mycoides JCVI-syn3.0, which harbors the smallest genome of any free-living organism (Hutchison et al., 2016). Notably, JCVI-syn3.0 was originally reported to contain 149 genes whose roles were unknown. Since then this number has shrunk to 91, and further reducing this figure still represents the next challenge in synthetic biology (Danchin and Fang, 2016).
Now, in eLife, Zan Luthey-Schulten and colleagues at the JCVI, the University of Illinois at Urbana-Champaign, the University of California at San Diego, and the University of Florida – including Marian Breuer as first author – report the first computational or 'in silico' model for a synthetic minimal organism (Breuer et al., 2019). The team reconstructed the complete set of chemical reactions that take place in the organism (that is, its metabolism). This effort bridges the gap between DNA sequences and molecular processes at the level of an entire biological system.
Breuer et al. performed their modeling work on M. mycoides JCVI-syn3.0A, a robust variation of JCVI-syn3.0 that contains 11 more genes. This was required because genome reduction involves a high number of genetic modifications, which tend to produce weaker cells that are harder to grow under laboratory conditions (Choe et al., 2019). To create their computational model, the team used the biochemical knowledge readily available for the parent strain JCVI-syn1.0 and identified the remaining candidate genes that participate in metabolism in JCVI-syn3.0A. These genes were then associated with cellular chemical reactions and, step-by-step, the entire metabolic network was modeled. This approach regroups the extensive knowledge on the metabolism of JCVI-syn3.0A in a single, highly valuable community resource that can help interrogate missing roles in the metabolic network and integrate experimental data.
Once a genome-scale model was obtained, it became possible to use it to perform computer simulations of different cellular phenotypes. Briefly, the in silico model represents the optimal metabolic state of the cell as an optimization problem on which constraints are applied. For instance, the metabolic models are constrained by the balance of reactants and products in a given chemical reaction (stoichiometry), and the conversion rates of the metabolites (flux bounds). Breuer et al. simulated the growth phenotype of JCVI-syn3.0A by optimizing for the production of cellular biomass, and then juxtaposed the predictions with real-life data, such as results from quantitative proteomics studies. In particular, they compared the genes that the model deemed essential with those highlighted when systematically mutating the genome of JCVI-syn3.0A. This revealed 30 genes that are required for survival but whose role is unknown. Understanding what these genes do is the next priority in the effort to complete the characterization of all molecular processes in a cell.
Overall, the model and experimental data generally agreed on their identification of essential genes; yet, a perfect match was not achieved, as is also the case when similar computational models are applied to natural organisms. Still, one would imagine that if this standard were within reach, it would be achieved first for minimal cells. To improve the quality of prediction, constraints that are more accurate need to be applied, and this would require additional information. For example, a completely defined media that contains only the necessary nutrients for JCVI-syn3.0A should be generated. It would also prove useful to have a precise biomass composition, that is, a detailed report of the proportion of major molecules and metabolites in the cell. Finally, many biochemical processes, such as isozymes (when enzymes with different structures catalyze the same reaction) or promiscuous reactions (when an enzyme can participate in many reactions) would need to be carefully investigated.
Such constraint-based modeling may be key to help with the generation of working genomes from square one, and in this regard, the model generated by Breuer et al. is the first of many steps to perfectly mirror a synthetic cell in silico. Next, the simulation could be expanded beyond metabolism to include other sets of biological processes, such as the gene expression machinery. This would help identify key constraints and trade-offs that cells must deal with in the struggle for life. In turn, these constraints could become the framework required to artificially design increasingly complex organisms, much like the hydrogen atom paved the way to understanding the behavior of more complex elements.
References
-
Adaptive laboratory evolution of a genome-reduced Escherichia coliNature Communications 10:935.https://doi.org/10.1038/s41467-019-08888-6
-
Unknown unknowns: essential genes in quest for functionMicrobial Biotechnology 9:530–540.https://doi.org/10.1111/1751-7915.12384
-
Special guest lecture the completeness of molecular biologyIsrael Journal of Medical Sciences 2:.
Article and author information
Author details
Jean-Christophe Lachance
Sébastien Rodrigue
Bernhard O Palsson
Publication history
Copyright
© 2019, Lachance et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Synthetic Biology: Minimal cells, maximal knowledge
eLife 8:e45379.
https://doi.org/10.7554/eLife.45379
Further reading
-
- Computational and Systems Biology
In eukaryotes, protein kinase signaling is regulated by a diverse array of post-translational modifications, including phosphorylation of Ser/Thr residues and oxidation of cysteine (Cys) residues. While regulation by activation segment phosphorylation of Ser/Thr residues is well understood, relatively little is known about how oxidation of cysteine residues modulate catalysis. In this study, we investigate redox regulation of the AMPK-related brain-selective kinases (BRSK) 1 and 2, and detail how broad catalytic activity is directly regulated through reversible oxidation and reduction of evolutionarily conserved Cys residues within the catalytic domain. We show that redox-dependent control of BRSKs is a dynamic and multilayered process involving oxidative modifications of several Cys residues, including the formation of intramolecular disulfide bonds involving a pair of Cys residues near the catalytic HRD motif and a highly conserved T-loop Cys with a BRSK-specific Cys within an unusual CPE motif at the end of the activation segment. Consistently, mutation of the CPE-Cys increases catalytic activity in vitro and drives phosphorylation of the BRSK substrate Tau in cells. Molecular modeling and molecular dynamics simulations indicate that oxidation of the CPE-Cys destabilizes a conserved salt bridge network critical for allosteric activation. The occurrence of spatially proximal Cys amino acids in diverse Ser/Thr protein kinase families suggests that disulfide-mediated control of catalytic activity may be a prevalent mechanism for regulation within the broader AMPK family.
-
- Computational and Systems Biology
- Genetics and Genomics
Obesity is a major risk factor for type 2 diabetes, dyslipidemia, cardiovascular disease, and hypertension. Intriguingly, there is a subset of metabolically healthy obese (MHO) individuals who are seemingly able to maintain a healthy metabolic profile free of metabolic syndrome. The molecular underpinnings of MHO, however, are not well understood. Here, we report that CTRP10/C1QL2-deficient mice represent a unique female model of MHO. CTRP10 modulates weight gain in a striking and sexually dimorphic manner. Female, but not male, mice lacking CTRP10 develop obesity with age on a low-fat diet while maintaining an otherwise healthy metabolic profile. When fed an obesogenic diet, female Ctrp10 knockout (KO) mice show rapid weight gain. Despite pronounced obesity, Ctrp10 KO female mice do not develop steatosis, dyslipidemia, glucose intolerance, insulin resistance, oxidative stress, or low-grade inflammation. Obesity is largely uncoupled from metabolic dysregulation in female KO mice. Multi-tissue transcriptomic analyses highlighted gene expression changes and pathways associated with insulin-sensitive obesity. Transcriptional correlation of the differentially expressed gene (DEG) orthologs in humans also shows sex differences in gene connectivity within and across metabolic tissues, underscoring the conserved sex-dependent function of CTRP10. Collectively, our findings suggest that CTRP10 negatively regulates body weight in females, and that loss of CTRP10 results in benign obesity with largely preserved insulin sensitivity and metabolic health. This female MHO mouse model is valuable for understanding sex-biased mechanisms that uncouple obesity from metabolic dysfunction.
